Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease

Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low Aβ amyloid may reflect other neurodegenerative processes. We aimed to determine the extent to which high Aβ amyloid influenced co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychology 2013-05, Vol.27 (3), p.322-332
Hauptverfasser: Lim, Yen Ying, Ellis, Kathryn A, Harrington, Karra, Kamer, Adrian, Pietrzak, Robert H, Bush, Ashley I, Darby, David, Martins, Ralph N, Masters, Colin L, Rowe, Christopher C, Savage, Greg, Szoeke, Cassandra, Villemagne, Victor L, Ames, David, Maruff, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 332
container_issue 3
container_start_page 322
container_title Neuropsychology
container_volume 27
creator Lim, Yen Ying
Ellis, Kathryn A
Harrington, Karra
Kamer, Adrian
Pietrzak, Robert H
Bush, Ashley I
Darby, David
Martins, Ralph N
Masters, Colin L
Rowe, Christopher C
Savage, Greg
Szoeke, Cassandra
Villemagne, Victor L
Ames, David
Maruff, Paul
description Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low Aβ amyloid may reflect other neurodegenerative processes. We aimed to determine the extent to which high Aβ amyloid influenced cognitive function in healthy older adults and adults with MCI. Method: Healthy controls (HC; n = 178) and adults with MCI ( n = 56) enrolled in the Australian Imaging, Biomarkers, and Lifestyle study, underwent positron emission tomography neuroimaging for Aβ amyloid and completed an extensive neuropsychological battery, assessing the cognitive domains of verbal and visual episodic memory, executive function, visuoconstruction, attention and processing speed, and language at baseline. Results: MCI with low Aβ performed worse than MCI with high Aβ on measures of executive function, attention, visuoconstruction and language. No differences were observed between HC high and low Aβ groups. When compared with HC with low Aβ, both MCI high and low Aβ groups performed worse on measures of episodic memory. However, only the MCI low Aβ group performed worse than HC low Aβ on measures of executive function, attention, visuoconstruction, and language. Conclusions: When compared with HC with low Aβ amyloid, MCI with high Aβ amyloid present with impairments restricted to episodic memory, and the episodic memory impairments in MCI with low Aβ amyloid were accompanied by impairments in executive function, attention, visuoconstruction, and language, suggesting that MCI with high Aβ amyloid reflects prodromal AD, although further longitudinal data is required to confirm this.
doi_str_mv 10.1037/a0032321
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1353987299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1353987299</sourcerecordid><originalsourceid>FETCH-LOGICAL-a406t-2f16a5c9847f65d92fa684cef292faf17c9a1c31d6c7283f46b9bf330ba0167d3</originalsourceid><addsrcrecordid>eNpt0N1qFDEYBuAgit1WwSuQgBaEMpqfmczkcFnULVR6osfx2_y0KZnMmMwU9ra8EK_JbLvtovQoITx5-b4XoTeUfKSEt5-AEM44o8_QgkpOK9o08jlakE7WVU1Jc4SOc74hpDyI5iU6Ylx0HaP1Av1cDVfRT_7W4tUQs_0126htxoPDa391jZd_fuNlvw2DN9hH_M0Hgw9fzvsRfOptnDBEg9cWwnS9xZfB2ISXZg5TfoVeOAjZvt6fJ-jHl8_fV-vq4vLr-Wp5UUFNxFQxRwU0WnZ160RjJHMgulpbx3ZXR1stgWpOjdAt67irxUZuHOdkA4SK1vAT9OE-d0xDWSJPqvdZ2xAg2mHOivKGy65lUhb67j96M8wplunuFOsIlewQqNOQc7JOjcn3kLaKErVrXT20XujbfeC86a15hA81F3C6B5A1BJcgap8PruW17Bpe3Nm9gxHUmLca0uR1sFnPKZWWVbRz0YorznYTvn9a_8v-AoOypHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353280192</pqid></control><display><type>article</type><title>Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease</title><source>MEDLINE</source><source>EBSCOhost APA PsycARTICLES</source><creator>Lim, Yen Ying ; Ellis, Kathryn A ; Harrington, Karra ; Kamer, Adrian ; Pietrzak, Robert H ; Bush, Ashley I ; Darby, David ; Martins, Ralph N ; Masters, Colin L ; Rowe, Christopher C ; Savage, Greg ; Szoeke, Cassandra ; Villemagne, Victor L ; Ames, David ; Maruff, Paul</creator><contributor>Rao, Stephen M</contributor><creatorcontrib>Lim, Yen Ying ; Ellis, Kathryn A ; Harrington, Karra ; Kamer, Adrian ; Pietrzak, Robert H ; Bush, Ashley I ; Darby, David ; Martins, Ralph N ; Masters, Colin L ; Rowe, Christopher C ; Savage, Greg ; Szoeke, Cassandra ; Villemagne, Victor L ; Ames, David ; Maruff, Paul ; AIBL Research Group ; The AIBL Research Group ; Rao, Stephen M</creatorcontrib><description>Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low Aβ amyloid may reflect other neurodegenerative processes. We aimed to determine the extent to which high Aβ amyloid influenced cognitive function in healthy older adults and adults with MCI. Method: Healthy controls (HC; n = 178) and adults with MCI ( n = 56) enrolled in the Australian Imaging, Biomarkers, and Lifestyle study, underwent positron emission tomography neuroimaging for Aβ amyloid and completed an extensive neuropsychological battery, assessing the cognitive domains of verbal and visual episodic memory, executive function, visuoconstruction, attention and processing speed, and language at baseline. Results: MCI with low Aβ performed worse than MCI with high Aβ on measures of executive function, attention, visuoconstruction and language. No differences were observed between HC high and low Aβ groups. When compared with HC with low Aβ, both MCI high and low Aβ groups performed worse on measures of episodic memory. However, only the MCI low Aβ group performed worse than HC low Aβ on measures of executive function, attention, visuoconstruction, and language. Conclusions: When compared with HC with low Aβ amyloid, MCI with high Aβ amyloid present with impairments restricted to episodic memory, and the episodic memory impairments in MCI with low Aβ amyloid were accompanied by impairments in executive function, attention, visuoconstruction, and language, suggesting that MCI with high Aβ amyloid reflects prodromal AD, although further longitudinal data is required to confirm this.</description><identifier>ISSN: 0894-4105</identifier><identifier>EISSN: 1931-1559</identifier><identifier>DOI: 10.1037/a0032321</identifier><identifier>PMID: 23688214</identifier><language>eng</language><publisher>Washington, DC: American Psychological Association</publisher><subject>Adult and adolescent clinical studies ; Aged ; Aged, 80 and over ; Alzheimer Disease - diagnosis ; Alzheimer Disease - diagnostic imaging ; Alzheimer Disease - metabolism ; Alzheimer's Disease ; Amyloid beta-Peptides - metabolism ; Attention ; Biological and medical sciences ; Brain - diagnostic imaging ; Brain - metabolism ; Cognition ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - diagnostic imaging ; Cognitive Dysfunction - metabolism ; Cognitive Impairment ; Consequence ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Early Diagnosis ; Episodic Memory ; Executive Function ; Female ; Geriatrics ; Human ; Humans ; Language ; Male ; Medical sciences ; Memory ; Middle Aged ; Mild Cognitive Impairment ; Neurodegenerative Diseases ; Neuroimaging ; Neurology ; Neuropsychological Tests ; Organic mental disorders. Neuropsychology ; Positron Emission Tomography ; Prodromal Symptoms ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Radionuclide Imaging</subject><ispartof>Neuropsychology, 2013-05, Vol.27 (3), p.322-332</ispartof><rights>2013 American Psychological Association</rights><rights>2015 INIST-CNRS</rights><rights>2013, American Psychological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a406t-2f16a5c9847f65d92fa684cef292faf17c9a1c31d6c7283f46b9bf330ba0167d3</citedby><orcidid>0000-0002-3698-2590 ; 0000-0002-6947-9537 ; 0000-0001-8259-9069 ; 0000-0001-9230-2978 ; 0000-0002-4828-9363 ; 0000-0001-9097-9037 ; 0000-0002-0308-5156</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27349853$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23688214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Rao, Stephen M</contributor><creatorcontrib>Lim, Yen Ying</creatorcontrib><creatorcontrib>Ellis, Kathryn A</creatorcontrib><creatorcontrib>Harrington, Karra</creatorcontrib><creatorcontrib>Kamer, Adrian</creatorcontrib><creatorcontrib>Pietrzak, Robert H</creatorcontrib><creatorcontrib>Bush, Ashley I</creatorcontrib><creatorcontrib>Darby, David</creatorcontrib><creatorcontrib>Martins, Ralph N</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Rowe, Christopher C</creatorcontrib><creatorcontrib>Savage, Greg</creatorcontrib><creatorcontrib>Szoeke, Cassandra</creatorcontrib><creatorcontrib>Villemagne, Victor L</creatorcontrib><creatorcontrib>Ames, David</creatorcontrib><creatorcontrib>Maruff, Paul</creatorcontrib><creatorcontrib>AIBL Research Group</creatorcontrib><creatorcontrib>The AIBL Research Group</creatorcontrib><title>Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease</title><title>Neuropsychology</title><addtitle>Neuropsychology</addtitle><description>Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low Aβ amyloid may reflect other neurodegenerative processes. We aimed to determine the extent to which high Aβ amyloid influenced cognitive function in healthy older adults and adults with MCI. Method: Healthy controls (HC; n = 178) and adults with MCI ( n = 56) enrolled in the Australian Imaging, Biomarkers, and Lifestyle study, underwent positron emission tomography neuroimaging for Aβ amyloid and completed an extensive neuropsychological battery, assessing the cognitive domains of verbal and visual episodic memory, executive function, visuoconstruction, attention and processing speed, and language at baseline. Results: MCI with low Aβ performed worse than MCI with high Aβ on measures of executive function, attention, visuoconstruction and language. No differences were observed between HC high and low Aβ groups. When compared with HC with low Aβ, both MCI high and low Aβ groups performed worse on measures of episodic memory. However, only the MCI low Aβ group performed worse than HC low Aβ on measures of executive function, attention, visuoconstruction, and language. Conclusions: When compared with HC with low Aβ amyloid, MCI with high Aβ amyloid present with impairments restricted to episodic memory, and the episodic memory impairments in MCI with low Aβ amyloid were accompanied by impairments in executive function, attention, visuoconstruction, and language, suggesting that MCI with high Aβ amyloid reflects prodromal AD, although further longitudinal data is required to confirm this.</description><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - diagnostic imaging</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer's Disease</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Attention</subject><subject>Biological and medical sciences</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Cognition</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - diagnostic imaging</subject><subject>Cognitive Dysfunction - metabolism</subject><subject>Cognitive Impairment</subject><subject>Consequence</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Early Diagnosis</subject><subject>Episodic Memory</subject><subject>Executive Function</subject><subject>Female</subject><subject>Geriatrics</subject><subject>Human</subject><subject>Humans</subject><subject>Language</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Mild Cognitive Impairment</subject><subject>Neurodegenerative Diseases</subject><subject>Neuroimaging</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Organic mental disorders. Neuropsychology</subject><subject>Positron Emission Tomography</subject><subject>Prodromal Symptoms</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Radionuclide Imaging</subject><issn>0894-4105</issn><issn>1931-1559</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0N1qFDEYBuAgit1WwSuQgBaEMpqfmczkcFnULVR6osfx2_y0KZnMmMwU9ra8EK_JbLvtovQoITx5-b4XoTeUfKSEt5-AEM44o8_QgkpOK9o08jlakE7WVU1Jc4SOc74hpDyI5iU6Ylx0HaP1Av1cDVfRT_7W4tUQs_0126htxoPDa391jZd_fuNlvw2DN9hH_M0Hgw9fzvsRfOptnDBEg9cWwnS9xZfB2ISXZg5TfoVeOAjZvt6fJ-jHl8_fV-vq4vLr-Wp5UUFNxFQxRwU0WnZ160RjJHMgulpbx3ZXR1stgWpOjdAt67irxUZuHOdkA4SK1vAT9OE-d0xDWSJPqvdZ2xAg2mHOivKGy65lUhb67j96M8wplunuFOsIlewQqNOQc7JOjcn3kLaKErVrXT20XujbfeC86a15hA81F3C6B5A1BJcgap8PruW17Bpe3Nm9gxHUmLca0uR1sFnPKZWWVbRz0YorznYTvn9a_8v-AoOypHw</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Lim, Yen Ying</creator><creator>Ellis, Kathryn A</creator><creator>Harrington, Karra</creator><creator>Kamer, Adrian</creator><creator>Pietrzak, Robert H</creator><creator>Bush, Ashley I</creator><creator>Darby, David</creator><creator>Martins, Ralph N</creator><creator>Masters, Colin L</creator><creator>Rowe, Christopher C</creator><creator>Savage, Greg</creator><creator>Szoeke, Cassandra</creator><creator>Villemagne, Victor L</creator><creator>Ames, David</creator><creator>Maruff, Paul</creator><general>American Psychological Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7RZ</scope><scope>PSYQQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3698-2590</orcidid><orcidid>https://orcid.org/0000-0002-6947-9537</orcidid><orcidid>https://orcid.org/0000-0001-8259-9069</orcidid><orcidid>https://orcid.org/0000-0001-9230-2978</orcidid><orcidid>https://orcid.org/0000-0002-4828-9363</orcidid><orcidid>https://orcid.org/0000-0001-9097-9037</orcidid><orcidid>https://orcid.org/0000-0002-0308-5156</orcidid></search><sort><creationdate>20130501</creationdate><title>Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults</title><author>Lim, Yen Ying ; Ellis, Kathryn A ; Harrington, Karra ; Kamer, Adrian ; Pietrzak, Robert H ; Bush, Ashley I ; Darby, David ; Martins, Ralph N ; Masters, Colin L ; Rowe, Christopher C ; Savage, Greg ; Szoeke, Cassandra ; Villemagne, Victor L ; Ames, David ; Maruff, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a406t-2f16a5c9847f65d92fa684cef292faf17c9a1c31d6c7283f46b9bf330ba0167d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - diagnostic imaging</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer's Disease</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Attention</topic><topic>Biological and medical sciences</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Cognition</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - diagnostic imaging</topic><topic>Cognitive Dysfunction - metabolism</topic><topic>Cognitive Impairment</topic><topic>Consequence</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Early Diagnosis</topic><topic>Episodic Memory</topic><topic>Executive Function</topic><topic>Female</topic><topic>Geriatrics</topic><topic>Human</topic><topic>Humans</topic><topic>Language</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Mild Cognitive Impairment</topic><topic>Neurodegenerative Diseases</topic><topic>Neuroimaging</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Organic mental disorders. Neuropsychology</topic><topic>Positron Emission Tomography</topic><topic>Prodromal Symptoms</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Radionuclide Imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lim, Yen Ying</creatorcontrib><creatorcontrib>Ellis, Kathryn A</creatorcontrib><creatorcontrib>Harrington, Karra</creatorcontrib><creatorcontrib>Kamer, Adrian</creatorcontrib><creatorcontrib>Pietrzak, Robert H</creatorcontrib><creatorcontrib>Bush, Ashley I</creatorcontrib><creatorcontrib>Darby, David</creatorcontrib><creatorcontrib>Martins, Ralph N</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Rowe, Christopher C</creatorcontrib><creatorcontrib>Savage, Greg</creatorcontrib><creatorcontrib>Szoeke, Cassandra</creatorcontrib><creatorcontrib>Villemagne, Victor L</creatorcontrib><creatorcontrib>Ames, David</creatorcontrib><creatorcontrib>Maruff, Paul</creatorcontrib><creatorcontrib>AIBL Research Group</creatorcontrib><creatorcontrib>The AIBL Research Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>APA PsycArticles®</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropsychology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lim, Yen Ying</au><au>Ellis, Kathryn A</au><au>Harrington, Karra</au><au>Kamer, Adrian</au><au>Pietrzak, Robert H</au><au>Bush, Ashley I</au><au>Darby, David</au><au>Martins, Ralph N</au><au>Masters, Colin L</au><au>Rowe, Christopher C</au><au>Savage, Greg</au><au>Szoeke, Cassandra</au><au>Villemagne, Victor L</au><au>Ames, David</au><au>Maruff, Paul</au><au>Rao, Stephen M</au><aucorp>AIBL Research Group</aucorp><aucorp>The AIBL Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease</atitle><jtitle>Neuropsychology</jtitle><addtitle>Neuropsychology</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>27</volume><issue>3</issue><spage>322</spage><epage>332</epage><pages>322-332</pages><issn>0894-4105</issn><eissn>1931-1559</eissn><abstract>Background: It has been proposed that only mild cognitive impairment (MCI) with high Aβ amyloid is indicative of incipient Alzheimer's disease (AD), yet MCI with low Aβ amyloid may reflect other neurodegenerative processes. We aimed to determine the extent to which high Aβ amyloid influenced cognitive function in healthy older adults and adults with MCI. Method: Healthy controls (HC; n = 178) and adults with MCI ( n = 56) enrolled in the Australian Imaging, Biomarkers, and Lifestyle study, underwent positron emission tomography neuroimaging for Aβ amyloid and completed an extensive neuropsychological battery, assessing the cognitive domains of verbal and visual episodic memory, executive function, visuoconstruction, attention and processing speed, and language at baseline. Results: MCI with low Aβ performed worse than MCI with high Aβ on measures of executive function, attention, visuoconstruction and language. No differences were observed between HC high and low Aβ groups. When compared with HC with low Aβ, both MCI high and low Aβ groups performed worse on measures of episodic memory. However, only the MCI low Aβ group performed worse than HC low Aβ on measures of executive function, attention, visuoconstruction, and language. Conclusions: When compared with HC with low Aβ amyloid, MCI with high Aβ amyloid present with impairments restricted to episodic memory, and the episodic memory impairments in MCI with low Aβ amyloid were accompanied by impairments in executive function, attention, visuoconstruction, and language, suggesting that MCI with high Aβ amyloid reflects prodromal AD, although further longitudinal data is required to confirm this.</abstract><cop>Washington, DC</cop><pub>American Psychological Association</pub><pmid>23688214</pmid><doi>10.1037/a0032321</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-3698-2590</orcidid><orcidid>https://orcid.org/0000-0002-6947-9537</orcidid><orcidid>https://orcid.org/0000-0001-8259-9069</orcidid><orcidid>https://orcid.org/0000-0001-9230-2978</orcidid><orcidid>https://orcid.org/0000-0002-4828-9363</orcidid><orcidid>https://orcid.org/0000-0001-9097-9037</orcidid><orcidid>https://orcid.org/0000-0002-0308-5156</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0894-4105
ispartof Neuropsychology, 2013-05, Vol.27 (3), p.322-332
issn 0894-4105
1931-1559
language eng
recordid cdi_proquest_miscellaneous_1353987299
source MEDLINE; EBSCOhost APA PsycARTICLES
subjects Adult and adolescent clinical studies
Aged
Aged, 80 and over
Alzheimer Disease - diagnosis
Alzheimer Disease - diagnostic imaging
Alzheimer Disease - metabolism
Alzheimer's Disease
Amyloid beta-Peptides - metabolism
Attention
Biological and medical sciences
Brain - diagnostic imaging
Brain - metabolism
Cognition
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - diagnostic imaging
Cognitive Dysfunction - metabolism
Cognitive Impairment
Consequence
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Early Diagnosis
Episodic Memory
Executive Function
Female
Geriatrics
Human
Humans
Language
Male
Medical sciences
Memory
Middle Aged
Mild Cognitive Impairment
Neurodegenerative Diseases
Neuroimaging
Neurology
Neuropsychological Tests
Organic mental disorders. Neuropsychology
Positron Emission Tomography
Prodromal Symptoms
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Radionuclide Imaging
title Cognitive Consequences of High Aβ Amyloid in Mild Cognitive Impairment and Healthy Older Adults: Implications for Early Detection of Alzheimer's Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A30%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Consequences%20of%20High%20A%CE%B2%20Amyloid%20in%20Mild%20Cognitive%20Impairment%20and%20Healthy%20Older%20Adults:%20Implications%20for%20Early%20Detection%20of%20Alzheimer's%20Disease&rft.jtitle=Neuropsychology&rft.au=Lim,%20Yen%20Ying&rft.aucorp=AIBL%20Research%20Group&rft.date=2013-05-01&rft.volume=27&rft.issue=3&rft.spage=322&rft.epage=332&rft.pages=322-332&rft.issn=0894-4105&rft.eissn=1931-1559&rft_id=info:doi/10.1037/a0032321&rft_dat=%3Cproquest_cross%3E1353987299%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1353280192&rft_id=info:pmid/23688214&rfr_iscdi=true